Finance

Lists
SYRS:OTCMKTS
Syros Pharmaceuticals Inc
USD 0,00040
0,00%
(0,00) 1D
9 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SYRS...
Open
USD 0,00
High
USD 0,00
Low
USD 0,00
Mkt. cap
12,88 k
Avg. vol.
14,84 k
Volume
110,23 k
52-wk high
USD 0,02
52-wk low
USD 0,00
Beta
1,66
Shares outstanding
26,83 m
No. of employees
68
Open
USD 0,00
High
USD 0,00
Low
USD 0,00
Mkt. cap
12,88 k
Avg. vol.
14,84 k
Volume
110,23 k
52-wk high
USD 0,02
52-wk low
USD 0,00
Beta
1,66
Shares outstanding
26,83 m
No. of employees
68
News stories
From web sources and news partners
About Syros Pharmaceuticals Inc
CEO-
Employees68
Founded2011
Headquarters-
Sector-
Websitesyros.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Des. 2023
Mrt. 2024
Jun. 2024
Sep. 2024
Revenue
386,00 k
-
-
-
Cost of goods sold
-
-
-
20,53 m
Cost of revenue
-
-
-
20,53 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
5,66 m
Operating expense
-
-
-
5,66 m
Total operating expenses
-
-
-
26,18 m
Operating income
-
-
-
-26,18 m
Other non operating income
-
-
-
20,30 m
EBT including unusual items
-
-
-
-6,40 m
EBT excluding unusual items
-
-
-
-6,40 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-6,40 m
Net profit margin
-
-
-
-
Earnings per share
-2,22
-0,10
-0,59
-0,16
Interest and investment income
-
-
-
793,00 k
Interest expense
-
-
-
-1,31 m
Net interest expenses
-
-
-
-519,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-25,86 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme